`

Nuvation Bio

Pharmaceutical Manufacturing

Last Updated: November 20, 2025
Sign Up to View More
Revenue
$7.87M
funding-icon Total Funding
$502.0M
Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs
Recent News

Frequently Asked Questions About Nuvation Bio

What does Nuvation bio do?+

Nuvation Bio is a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bios portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the worlds leading prostate cancer medicines. Nuvation Bio has offices in New York, San Francisco, and Shanghai

What is Nuvation bio's industry? +

Nuvation bio operates in the Pharmaceutical manufacturing industry.

What is Nuvation bio's revenue? +

Nuvation bio's revenue is $7.87m

What is Nuvation bio's company size? +

Nuvation bio has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free